company background image
6885

JiangsuJibeier PharmaceuticalSHSE:688566 Stock Report

Market Cap

CN¥4.0b

7D

-2.1%

1Y

-26.9%

Updated

07 Dec, 2021

Data

Company Financials
688566 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends3/6

688566 Stock Overview

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines.

Price History & Performance

Summary of all time highs, changes and price drops for JiangsuJibeier Pharmaceutical
Historical stock prices
Current Share PriceCN¥21.28
52 Week HighCN¥29.50
52 Week LowCN¥19.80
Beta0
1 Month Change5.40%
3 Month Change-8.98%
1 Year Change-26.95%
3 Year Changen/a
5 Year Changen/a
Change since IPO-53.44%

Recent News & Updates

Shareholder Returns

688566CN PharmaceuticalsCN Market
7D-2.1%-2.5%-0.4%
1Y-26.9%-4.4%7.5%

Return vs Industry: 688566 underperformed the CN Pharmaceuticals industry which returned -4.4% over the past year.

Return vs Market: 688566 underperformed the CN Market which returned 7.5% over the past year.

Price Volatility

Is 688566's price volatile compared to industry and market?
688566 volatility
688566 Average Weekly Movement3.2%
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement6.1%
10% most volatile stocks in CN Market9.9%
10% least volatile stocks in CN Market3.5%

Stable Share Price: 688566 is less volatile than 75% of CN stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: 688566's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001867n/ahttps://www.jibeier.com.cn

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company’s products cover various therapeutic areas, such as improving white blood cells, enhancing immunity, treating joint diseases, anti-hypertension, anti-eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach diseases, and other diseases. The company was founded in 2001 and is based in Zhenjiang, China.

JiangsuJibeier Pharmaceutical Fundamentals Summary

How do JiangsuJibeier Pharmaceutical's earnings and revenue compare to its market cap?
688566 fundamental statistics
Market CapCN¥3.98b
Earnings (TTM)CN¥127.14m
Revenue (TTM)CN¥529.84m

31.3x

P/E Ratio

7.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
688566 income statement (TTM)
RevenueCN¥529.84m
Cost of RevenueCN¥61.79m
Gross ProfitCN¥468.05m
ExpensesCN¥340.90m
EarningsCN¥127.14m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.68
Gross Margin88.34%
Net Profit Margin24.00%
Debt/Equity Ratio0.0%

How did 688566 perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

71%

Payout Ratio

Valuation

Is JiangsuJibeier Pharmaceutical undervalued compared to its fair value and its price relative to the market?

31.29x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 688566 (CN¥21.28) is trading above our estimate of fair value (CN¥12.07)

Significantly Below Fair Value: 688566 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 688566 is good value based on its PE Ratio (31.3x) compared to the CN Pharmaceuticals industry average (31.6x).

PE vs Market: 688566 is good value based on its PE Ratio (31.3x) compared to the CN market (36.4x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 688566's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 688566 is good value based on its PB Ratio (2.6x) compared to the CN Pharmaceuticals industry average (2.7x).


Future Growth

How is JiangsuJibeier Pharmaceutical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

23.5%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as JiangsuJibeier Pharmaceutical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has JiangsuJibeier Pharmaceutical performed over the past 5 years?

12.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 688566 has high quality earnings.

Growing Profit Margin: 688566's current net profit margins (24%) are higher than last year (21.7%).


Past Earnings Growth Analysis

Earnings Trend: 688566's earnings have grown by 12% per year over the past 5 years.

Accelerating Growth: 688566's earnings growth over the past year (8.1%) is below its 5-year average (12% per year).

Earnings vs Industry: 688566 earnings growth over the past year (8.1%) underperformed the Pharmaceuticals industry 14.8%.


Return on Equity

High ROE: 688566's Return on Equity (8.1%) is considered low.


Financial Health

How is JiangsuJibeier Pharmaceutical's financial position?


Financial Position Analysis

Short Term Liabilities: 688566's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥112.3M).

Long Term Liabilities: 688566's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥87.1M).


Debt to Equity History and Analysis

Debt Level: 688566 is debt free.

Reducing Debt: 688566 had no debt 5 years ago.

Debt Coverage: 688566 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 688566 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is JiangsuJibeier Pharmaceutical current dividend yield, its reliability and sustainability?

2.26%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 688566's dividend (2.26%) is higher than the bottom 25% of dividend payers in the CN market (0.4%).

High Dividend: 688566's dividend (2.26%) is in the top 25% of dividend payers in the CN market (1.81%)


Stability and Growth of Payments

Stable Dividend: Too early to tell whether 688566's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if 688566's dividend payments are increasing as they only just started paying a dividend.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (70.7%), 688566's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

JiangsuJibeier Pharmaceutical has no CEO, or we have no data on them.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

JiangsuJibeier Pharmaceutical Co., Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: JiangsuJibeier Pharmaceutical Co., Ltd.
  • Ticker: 688566
  • Exchange: SHSE
  • Founded: 2001
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CN¥3.978b
  • Shares outstanding: 186.94m
  • Website: https://www.jibeier.com.cn

Number of Employees


Location

  • JiangsuJibeier Pharmaceutical Co., Ltd.
  • High-tech Industrial Development Zone
  • Zhenjiang
  • Jiangsu Province
  • 212000
  • China

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/12/07 16:33
End of Day Share Price2021/12/07 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.